Communication in drug safety: a report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (ISoP), 2010.
about
A descriptive review of additional risk minimisation measures applied to EU centrally authorised medicines 2006-2015.The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.Focusing on risk communication about medicines: why now?The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.
P2860
Communication in drug safety: a report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (ISoP), 2010.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Communication in drug safety: ...... harmacovigilance (ISoP), 2010.
@en
Communication in drug safety: ...... harmacovigilance (ISoP), 2010.
@nl
type
label
Communication in drug safety: ...... harmacovigilance (ISoP), 2010.
@en
Communication in drug safety: ...... harmacovigilance (ISoP), 2010.
@nl
prefLabel
Communication in drug safety: ...... harmacovigilance (ISoP), 2010.
@en
Communication in drug safety: ...... harmacovigilance (ISoP), 2010.
@nl
P2093
P1433
P1476
Communication in drug safety: ...... pharmacovigilance (ISoP), 2010
@en
P2093
Bruce P J Hugman
Hélène Théophile
I Ralph Edwards
Priya Bahri
P304
P356
10.2165/11594430-000000000-00000
P50
P577
2011-10-01T00:00:00Z
P6179
1033426480